Houlihan Lokey (HLI): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil
We recently published a list of . In this article, we are going to take a look at where Houlihan Lokey, Inc. (NYSE:HLI) stands against other stocks that Wall Street is calling bullish amid market turmoil.
The S&P 500 is down 8.6% in a month while the Nasdaq has lost nearly 13%. Markets continue to scare retail investors as stock after stock struggles to deal with the aftermath of Donald Trump's unpredictable and aggressive policies.
While it is advisable to stay out of the market till the dust settles, one also can't deny that it is times like these that bring opportunities. We decided to come up with a list of stocks that are expected to go up even in the existing gloomy environment.
To come up with the list of 10 stocks that Wall Street is bullish on, we looked at stocks that were recently upgraded by analysts and have performed well in the last 5 days of trading.
A close-up of hands shaking to signify a newly negotiated financial restructuring transaction.
Houlihan Lokey, Inc. (NYSE:HLI) operates as an investment banking company and offers merger and acquisition (M&A), financial and valuation advisory, and other services. The company operates through Corporate Finance (CF), Financial and Valuation Advisory (FVA), and Financial Restructuring (FR) segments.
The investment banking firm was recently double-upgraded by Wells Fargo from Underweight to Overweight. This upgrade came on the back of the company's 'balanced/all-weather business model, which is well-positioned to benefit from market fluctuations. According to the analysts at Wells Fargo, HLI's robust business model offers stability and protects against market volatility through its diversified portfolio and counter-cyclical restructuring franchise.
'All told, we expect the market to pay a premium for HLI and see it as a compelling relative outperformer.'
Houlihan Lokey (NYSE:HLI) recently announced its Q3 financial results demonstrating a strong performance. As per the results, the company grew its revenue by 24% YoY accompanied by a 34% YoY increase in the adjusted EPS. On top of this solid performance, the company presented a positive outlook for FY2026.
The management is optimistic that the company's restructuring and M&A activities will keep growing, with the potential for further expansion in market share in 2026.
Overall, HLI ranks 5th on our list of stocks that Wall Street is calling bullish amid market turmoil. While we acknowledge the potential of HLI as a leading investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is as promising as HLI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
![From Chandelier to Cube: The Versatile Forms of 6:AM's '▢ [quadrato]' Collection](/_next/image?url=https%3A%2F%2Fimage-cdn.hypb.st%2Fhttps%253A%252F%252Fhypebeast.com%252Fimage%252F2025%252F06%252F12%252F6am-quadrato-new-lighting-collection-two-fold-silence-exhibition-milano-design-week-2025-tw.jpg%3Fw%3D1080%26cbr%3D1%26q%3D90%26fit%3Dmax&w=3840&q=100)
![From Chandelier to Cube: The Versatile Forms of 6:AM's '▢ [quadrato]' Collection](https://hypebeast.com/dist/hypebeast/images/hypebeast-logo.4d6a6810.svg){kind=logo}
Hypebeast
an hour ago
- Hypebeast
From Chandelier to Cube: The Versatile Forms of 6:AM's '▢ [quadrato]' Collection
Summary 6:AM Glassworkshas recently unveiled its new '▢ [quadrato]' collection, a visual statement that reinterprets Murano-blown glass through essential lines and geometric forms. This innovative series draws inspiration from the industrial lamps of the 1920s, blending the rational language of the Bauhaus movement with the minimalist aesthetic championed by Malevich. The resulting collection spotlights modular lighting pieces, where intricate details, such as air bubbles, grooves and transparencies, contribute to each product's unique narrative. ' ▢ [quadrato]' was debuted during this year'sMilan Design Week, where it was featured within theTwo-Fold Silenceexhibition held at Piscina Cozzi — a historic former public bath. This setting provided a unique immersion into the brand's creative universe, allowing visitors to experience the interplay of rationality and instinct, as well as form and intuition that define the collection. The collection offers a versatile range of lighting solutions, available in suspension, wall, table, and floor variations. A notable piece within the collection is the ▢ [EXIT], which features screen-printed lattimo glass and a painted iron structure. Inspired by emergency lamps from the '20s, its pattern replicates pre-plastic designs, blending functionality with artistic craftsmanship in a striking red and white palette. Another standout piece worth mentioning is the ▢ [quadrato 36], a contemporary reinterpretation of the classic chandelier. This striking installation, composed of 36 hand-blown glass cubes, recalls the purity of Bauhaus aesthetics. Its planar arrangement emphasizes geometric precision, forming a floating grid of illuminated cubes that can be inquired about upon request. Crafted from lattimo handblown glass and powder-coated iron, the '▢ [quadrato] collection' exemplifies 6:AM's commitment to transforming functional objects into aesthetic and architectural pieces. Prices vary between €900 – €5,200 EUR (approx $1,035 – $5,978 USD) across the collection, with the exception of ▢ [quadrato 3 being available upon request. For more information, head over to 6:30's officialwebsite.
Business Wire
an hour ago
- Business Wire
Prime Success Responds to Sinovac Biotech's False and Misleading Claims
HONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, 'Prime Success' or 'we'), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) ('Sinovac' or the 'Company') with ownership of approximately 8% of the Company's outstanding shares, today issued the following letter in response to the Company's recent false and misleading claims relating to the upcoming Special Meeting of Shareholders (the 'Special Meeting') scheduled for July 8, 2025. The full text of the letter is below and available at Dear fellow Sinovac shareholders, Prime Success, L.P. (together with its affiliates, 'Prime Success' or 'we'), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) ('Sinovac' or the 'Company'), continues to be disappointed by the current Board's ('1Globe Activist Board') distortion of the facts about what is at stake at the upcoming Special Meeting of Shareholders (the 'Special Meeting') scheduled for July 8, 2025. In our June 10 letter we addressed several of the 1Globe Activist Board's misstatements and are taking the opportunity to remind all shareholders why the 1Globe Activist Board cannot be trusted: 1. Prime Success is insisting that a dividend be distributed – for all shareholders The 1Globe Activist Board's false comments are just not credible – why would any investor be against receiving a dividend? The 1Globe Activist Board wants you to believe that Prime Success is the reason that dividends have not been distributed, but we are not the Company and are not on the Board, and dividend distribution decisions are not ours to make. We can only continue to advocate on behalf of all shareholders that they should be made. Under the leadership of a SAIF Partners IV L.P. ('SAIF') nominated Board — composed of seasoned professionals with proven governance experience, deep operational insight, and a track record of building real, lasting value — we are confident that the pattern of internal conflict and ongoing litigation fueled by the 1Globe Activist Board can be broken, and shareholders can look forward to more future dividends. But that will not be possible with the 1Globe Activist Board in power as they have made clear they prioritize endless litigation over the Company's long-term success. 2. The 1Globe Activist Board is deliberately baiting shareholders by setting the dividend distribution date for one day after the Special Meeting. We call upon the Company to make dividend distribution before the Special Meeting The 1Globe Activist Board deliberately set the dividend date for one day after the Special Meeting which creates the false impression that shareholders must vote for the incumbents to receive the dividends. But the upcoming Special Meeting will determine the Company's future direction and the long-term interests of all shareholders. We call on the 1Globe Activist Board to allow for a fair, pro rata distribution of dividends and to move the date of the dividend distribution to before the Special Meeting so the meeting can refocus on its proper purpose: electing a competent Board. 3. The 1Globe Activist Board distorts historic facts to aggrandize 1Globe and smear legitimate investors Let's compare facts against rhetoric of the 1Globe Activist Board. Over the past seven years, what have we contributed to the Company? The critical lifeline investments from Prime Success and Vivo Capital, LLC, combined with management's determined efforts, enabled Sinovac to seize a pivotal opportunity: the development of CoronaVac. This initiative ultimately resulted in the delivery of billions of doses to over 60 countries, generating substantial revenues while saving countless lives. Without the success of CoronaVac, there would not be any sizable dividend to distribute now. In contrast, what has 1Globe done for the Company? It has initiated multi-jurisdictional litigation against Sinovac, leading to a waste of company resources. The 1Globe Activist Board's mischaracterization of 1Globe and Prime Success' relative contribution to Sinovac and its shareholders reveals its deeply partisan nature. 4. Shareholders: looking forward, it's time to focus on what truly matters – the future of your investment in Sinovac Sinovac needs a Board that will roll up its sleeves and run the business, guiding the Company forward on a stable, productive path. The slate put forward by SAIF, consisting of representatives from all shareholders owning more than 5% of the Company's equity stake, many of whom possess deep industry experience, achieves exactly that. We urge all shareholders to focus on the future and choose the leadership that will best secure our Company's success in the years to come. We look forward to continuing to make our case for change to our fellow shareholders and encourage them to wait for and read SAIF's proxy materials before voting for the Special Meeting on July 8, 2025. Sincerely, Prime Success, L.P. About Prime Success, L.P. Prime Success is an investment vehicle established by Advantech Capital specifically to invest in Sinovac and Sinovac Life Sciences; Advantech Capital is a private equity fund established in 2016 with a focus on innovation-driven growth opportunities in China.
Business Insider
an hour ago
- Business Insider
Cantor Downgrades Joby Aviation Stock (JOBY) Due to Lack of Near-Term Upside
Cantor Fitzgerald downgraded electric vertical takeoff and landing (eVTOL) aircraft maker Joby Aviation (JOBY) to Hold from Buy with a price target of $9 due to a lack of near-term upside in the stock. While JOBY stock plunged about 8% on Thursday due to the rating downgrade, it has rallied 26.5% over the past month. As a result, the stock is up 9.1% year-to-date, thanks to a favorable executive order signed by U.S. President Donald Trump and the announcement of new deals. Confident Investing Starts Here: Indeed, the executive order would direct the Transportation Department to develop a program to accelerate eVTOL operations in the U.S., which is expected to benefit players like Joby Aviation and Archer Aviation (ACHR). This comes after Joby Aviation signed a Memorandum of Understanding (MoU) earlier this month with Abdul Latif Jameel to explore establishing a distribution agreement in Saudi Arabia for the company's electric aircraft. The agreement involves the potential delivery of up to 200 Joby aircraft and related services that are valued at about $1 billion. Cantor Moves to the Sidelines on JOBY Stock Interestingly, Cantor analyst Andres Sheppard admitted that Joby Aviation remains one of the best-positioned companies in the eVTOL sector, given its partnerships with Toyota (TM), Delta Air Lines (DAL), and the U.S. Department of Defense. However, the 4-star analyst finds JOBY stocks' valuation to be stretched, following a 60% rally over the past three months and an almost 90% gain in the past year. 'We don't see current levels as a good entry point for investors,' said Sheppard. The analyst noted that while Joby Aviation has solid liquidity, it also has one of the highest cash burn rates in the sector. In fact, the company ended Q1 2025 with about $1.3 billion in total liquidity, including Toyota's $250 million funding, but expects to spend between $500 million and $540 million in 2025. Additionally, Sheppard cautioned about delays in U.S. certification and doesn't expect Joby Aviation to secure full FAA Type Certification until at least the second half of 2026. Finally, Sheppard pointed out persistent uncertainty around the company's unit economics, such as pricing and deployment costs of its air taxi service. Is Joby Stock a Good Buy? Wall Street has a Moderate Buy consensus rating on Joby Aviation stock based on three Buys, three Holds, and one Sell recommendation. Furthermore, the average JOBY stock price target of $8.86 indicates that the stock is trading close to fair value.
